1. Analysis of French generic medicines retail market: why the use of generic medicines is limited. (December 2014) Authors: Dylst, Pieter; Vulto, Arnold; Simoens, Steven Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 14:Number 6(2014) Page Start: 795 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analysis of French generic medicines retail market: why the use of generic medicines is limited. (December 2014) Authors: Dylst, Pieter; Vulto, Arnold; Simoens, Steven Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 14:Number 6(2014) Page Start: 795 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Analysis of Spanish generic medicines retail market: recommendations to enhance long-term sustainability. (June 2014) Authors: Dylst, Pieter; Vulto, Arnold G; Simoens, Steven Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 14:Number 3(2014) Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Analysis of Spanish generic medicines retail market: recommendations to enhance long-term sustainability. (June 2014) Authors: Dylst, Pieter; Vulto, Arnold G; Simoens, Steven Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 14:Number 3(2014) Page Start: 345 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Analysis of the Italian generic medicines retail market: recommendations to enhance long-term sustainability. (February 2014) Authors: Dylst, Pieter; Vulto, Arnold; Simoens, Steven Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 15:Number 1(2015) Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Health technologies for rare diseases: does conventional HTA still apply?. (June 2014) Authors: Simoens, Steven Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 14:Number 3(2014) Page Start: 315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Health technologies for rare diseases: does conventional HTA still apply?. (June 2014) Authors: Simoens, Steven Journal: Expert review of pharmacoeconomics & outcomes research Issue: Volume 14:Number 3(2014) Page Start: 315 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Incremental cost per quality-adjusted life year gained? The need for alternative methods to evaluate medical interventions for ultra-rare disorders. (July 2014) Authors: Schlander, Michael; Garattini, Silvio; Holm, Søren; Kolominsky-Rabas, Peter; Nord, Erik; Persson, Ulf; Postma, Maarten; Richardson, Jeff; Simoens, Steven; Solà Morales, Oriol de; Tolley, Keith; Toumi, Mondher Journal: Journal of comparative effectiveness research Issue: Volume 3:Number 4(2014) Page Start: 399 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗